Margin accretion - against the backdrop of what a lot of anecdotal evidence is pointing to a tough operating environment - is quite credible.
Suggests that the contract pricing part of their business - clearly one of the most mission critical bits - is something they are getting right.
I went from thinking in recent weeks about selling my shares in SRG, to ending up buying more shares this morning.
It happens like that sometimes.
Two years ago, I used to think, "quality-wise, a 4 out of 10 business".
Developments since then have caused me to upgrade to a score of 5 out 10 quality business.
Which is being valued like a 3 out of 10 business.
.
- Forums
- ASX - By Stock
- Ann: FY21 Guidance Update & FY22 Outlook Announcement
Margin accretion - against the backdrop of what a lot of...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRG (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.19 |
Change
0.030(2.60%) |
Mkt cap ! $715.6M |
Open | High | Low | Value | Volume |
$1.16 | $1.19 | $1.16 | $2.294M | 1.953M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16740 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 38390 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16740 | 1.175 |
4 | 25696 | 1.170 |
5 | 63482 | 1.160 |
1 | 8647 | 1.155 |
2 | 5030 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 31740 | 3 |
1.195 | 18268 | 2 |
1.200 | 40028 | 6 |
1.205 | 20000 | 1 |
1.220 | 778 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
SRG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online